State of Alaska Department of Revenue’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Hold
6,120
﹤0.01% 2137
2026
Q1
$14K Hold
6,120
﹤0.01% 2143
2025
Q4
$31K Hold
6,120
﹤0.01% 2009
2025
Q3
$25K Buy
+6,120
New +$28.4K ﹤0.01% 1951
2023
Q1
Sell
-49,226
Closed -$132K 1634
2022
Q4
$132K Buy
49,226
+293
+0.6% +$855 ﹤0.01% 1621
2022
Q3
$158K Buy
48,933
+4,633
+10% +$20.9K ﹤0.01% 1611
2022
Q2
$216K Buy
44,300
+450
+1% +$2.77K ﹤0.01% 1586
2022
Q1
$334K Sell
43,850
-780
-2% -$6.04K ﹤0.01% 1529
2021
Q4
$412K Sell
44,630
-1,270
-3% -$13.5K ﹤0.01% 1524
2021
Q3
$653K Buy
45,900
+11,300
+33% +$175K 0.01% 1323
2021
Q2
$575K Buy
+34,600
New +$645K 0.01% 1389

Other funds holding ORGO

State of Alaska Department of Revenue's ORGO Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 6,120 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

State of Alaska Department of Revenue first reported a position in ORGO in Q2 2021 and has held it in 11 quarters since. The position peaked at $653K in Q3 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • State of Alaska Department of Revenue held 6,120 shares of Organogenesis Holdings worth $14K as of Q2 2026.
  • State of Alaska Department of Revenue left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #2137 holding.
  • State of Alaska Department of Revenue first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 11 quarters since.
  • State of Alaska Department of Revenue's Organogenesis Holdings position peaked at $653K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.